NEW YORK (360Dx) – Researchers at McGill University have developed a microfluidic immunohistochemistry assay that enables multiplexed protein detection while retaining sample structural and spatial information.

The group has launched a spinout, Parallex BioAssays, to commercialize the underlying technology, which uses slides preprinted with antibodies to target proteins to enable what Huiyan Li, a postdoc in the lab of McGill professor David Juncker, said is a streamlined and inexpensive approach to multiplexed IHC.